The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.

NCT06208072 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Primary Hypertension
Obesity

Interventions

DRUG: Irbesartan 150mg
DRUG: Eplerenone 25 mg

Sponsor

Hippocration General Hospital

Collaborators

[object Object]